This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bromuro, C. Articles by Cassone, A. Search for Related Content PubMed PubMed Citation Articles by Bromuro, C. Articles by Cassone, A.

Interplay between Protective and Inhibitory Antibodies Dictates the Outcome of Experimentally Disseminated Candidiasis in Recipients of a Candida albicans Vaccine

Department of Bacteriology and Medical Mycology, Istituto Superiore di Sanità, Rome,¹ Microbiology Section, Department of Pathology and Laboratory Medicine, University of Parma, Parma, Italy²

Received 25 February 2002/ Returned for modification 26 March 2002/ Accepted 5 July 2002

Mice immunized with heat-inactivated, whole yeast-form cells (Y cells) of Candida albicans developed intense, specific humoral and cell-mediated immune responses. However, they were modestly protected against a lethal challenge by the fungus, and their sera did not confer passive protection upon nonimmunized animals. Surprisingly, this immune serum conferred an elevated degree of passive protection to normal and SCID mice when preadsorbed on whole C. albicans cells. After adsorption, no antibodies specific to mannoprotein (MP)-rich extracts or secretions were detected by indirect enzyme-linked immunosorbent assay and no serum reaction with the fungal cell surface was seen in immunofluorescence assays. However, this serum had totally preserved the level of other antibodies, in particular those reacting with ß-1,3 and ß-1,6 glucan (GG). The hypothesis that anti-GG antibodies contributed to the passive protection was suggested by the following circumstantial evidence: (i) mice immunized with C. albicans cells treated with dithiothreitol and protease (YDP cells), which exposed GG on their surfaces and generated anti-GG but not anti-MP antibodies, were substantially protected against a lethal fungus challenge; (ii) the sera, and their immunoglobulin fractions, of mice immunized with YDP cells transferred protection to nonimmune animals; and (iii) this passive protection was substantially abolished by preadsorption on GG but not on intact cells. Overall, our findings demonstrate that some anti-Candida antibodies can block the protective potential of immune serum, a potential to which anti-GG antibodies appear to contribute. Our observations may also help explain why subjects with elevated anti-Candida antibody titers, inclusive of anti-MP and anti-GG antibodies, remain nonetheless susceptible to invasive candidiasis.

Editor: S. H. E. Kaufmann

This article has been cited by other articles:

• Nisini, R., Torosantucci, A., Romagnoli, G., Chiani, P., Donati, S., Gagliardi, M. C., Teloni, R., Sargentini, V., Mariotti, S., Iorio, E., Cassone, A. (2007). {beta}-Glucan of Candida albicans cell wall causes the subversion of human monocyte differentiation into dendritic cells. J. Leukoc. Biol. 82: 1136-1142 [Abstract] [Full Text]  
• Cassone, A., De Bernardis, F., Santoni, G. (2007). Anticandidal Immunity and Vaginitis: Novel Opportunities for Immune Intervention. Infect. Immun. 75: 4675-4686 [Full Text]  
• Murciano, C., Villamon, E., Yanez, A., O'Connor, J.-E., Gozalbo, D., Gil, M. L. (2006). Impaired immune response to Candida albicans in aged mice.. J Med Microbiol 55: 1649-1656 [Abstract] [Full Text]  
• Xin, H., Cutler, J. E. (2006). Hybridoma Passage In Vitro May Result in Reduced Ability of Antimannan Antibody To Protect against Disseminated Candidiasis. Infect. Immun. 74: 4310-4321 [Abstract] [Full Text]  
• Sevilla, M. J., Robledo, B., Rementeria, A., Moragues, M. D., Ponton, J. (2006). A Fungicidal Monoclonal Antibody Protects against Murine Invasive Candidiasis.. Infect. Immun. 74: 3042-3045 [Abstract] [Full Text]  
• Torosantucci, A., Bromuro, C., Chiani, P., De Bernardis, F., Berti, F., Galli, C., Norelli, F., Bellucci, C., Polonelli, L., Costantino, P., Rappuoli, R., Cassone, A. (2005). A novel glyco-conjugate vaccine against fungal pathogens. J. Exp. Med. 202: 597-606 [Abstract] [Full Text]  
• Ibrahim, A. S., Spellberg, B. J., Avenissian, V., Fu, Y., Filler, S. G., Edwards, J. E. Jr. (2005). Vaccination with Recombinant N-Terminal Domain of Als1p Improves Survival during Murine Disseminated Candidiasis by Enhancing Cell-Mediated, Not Humoral, Immunity. Infect. Immun. 73: 999-1005 [Abstract] [Full Text]  
• Masuoka, J. (2004). Surface Glycans of Candida albicans and Other Pathogenic Fungi: Physiological Roles, Clinical Uses, and Experimental Challenges. Clin. Microbiol. Rev. 17: 281-310 [Abstract] [Full Text]  
• Kondori, N., Edebo, L., Mattsby-Baltzer, I. (2004). Circulating {beta} (1-3) Glucan and Immunoglobulin G Subclass Antibodies to Candida albicans Cell Wall Antigens in Patients with Systemic Candidiasis. CVI 11: 344-350 [Abstract] [Full Text]  
• Wellington, M., Bliss, J. M., Haidaris, C. G. (2003). Enhanced Phagocytosis of Candida Species Mediated by Opsonization with a Recombinant Human Antibody Single-Chain Variable Fragment. Infect. Immun. 71: 7228-7231 [Abstract] [Full Text]